Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells

Michael Grusch, Georg Rosenberger, Gerhard Fuhrmann, Katja Braun, Birgit Titscher, Thomas Szekeres, Monika Fritzer-Skekeres, Georg Oberhuber, Karsten Krohn, Markus Hengstschlaeger, Georg Krupitza, Hiremagalur N. Jayaram

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

One of the mechanisms of action of a new oncolytic agent, benzamide riboside (BR) is by inhibiting inosine 5'-monophosphate dehydrogenase (IMPDH) which catalyzes the formation of xanthine 5'-monophosphate from inosine 5'-monophosphate and nicotinamide adenine dinucleotide, thereby restricting the biosynthesis of guanylates. In the present study BR (10-20 μM) induced apoptosis in a human ovarian carcinoma N.1 cell line (a monoclonal derivative of its heterogenous parent line HOC-7). This was ascertained by DNA fragmentation, TUNEL assay, [poly(ADP)ribose polymerase]-cleavage and alteration in cell morphology. Apoptosis was accompanied by sustained c-Myc expression, concurrent down-regulation of cdc25A mRNA and protein, and by inhibition of Cdk2 activity. Both Cdk2 and cdc25A are G1 phase specific genes and Cdk2 is the target of Cdc25A. These studies demonstrate that BR exhibits dual mechanisms of action, first by inhibiting IMPDH, and second by inducing apoptosis, which is associated with repression of components of the cell cycle that are downstream of constitutive c-Myc expression.

Original languageEnglish
Pages (from-to)736-744
Number of pages9
JournalCell Death and Differentiation
Volume6
Issue number8
StatePublished - Aug 1999

Fingerprint

IMP Dehydrogenase
Apoptosis
Carcinoma
Inosine Monophosphate
Xanthine
Poly(ADP-ribose) Polymerases
In Situ Nick-End Labeling
G1 Phase
DNA Fragmentation
NAD
Cell Cycle
Down-Regulation
Cell Line
Messenger RNA
Genes
3-(1-deoxyribofuranosyl)benzamide
Proteins

Keywords

  • Apoptosis
  • Benzamide riboside
  • c-myc induction
  • Cdc25A repression
  • Cyclin D1/prad 1 expression
  • IMP dehydrogenase inhibitor

ASJC Scopus subject areas

  • Cell Biology

Cite this

Grusch, M., Rosenberger, G., Fuhrmann, G., Braun, K., Titscher, B., Szekeres, T., ... Jayaram, H. N. (1999). Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells. Cell Death and Differentiation, 6(8), 736-744.

Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells. / Grusch, Michael; Rosenberger, Georg; Fuhrmann, Gerhard; Braun, Katja; Titscher, Birgit; Szekeres, Thomas; Fritzer-Skekeres, Monika; Oberhuber, Georg; Krohn, Karsten; Hengstschlaeger, Markus; Krupitza, Georg; Jayaram, Hiremagalur N.

In: Cell Death and Differentiation, Vol. 6, No. 8, 08.1999, p. 736-744.

Research output: Contribution to journalArticle

Grusch, M, Rosenberger, G, Fuhrmann, G, Braun, K, Titscher, B, Szekeres, T, Fritzer-Skekeres, M, Oberhuber, G, Krohn, K, Hengstschlaeger, M, Krupitza, G & Jayaram, HN 1999, 'Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells', Cell Death and Differentiation, vol. 6, no. 8, pp. 736-744.
Grusch M, Rosenberger G, Fuhrmann G, Braun K, Titscher B, Szekeres T et al. Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells. Cell Death and Differentiation. 1999 Aug;6(8):736-744.
Grusch, Michael ; Rosenberger, Georg ; Fuhrmann, Gerhard ; Braun, Katja ; Titscher, Birgit ; Szekeres, Thomas ; Fritzer-Skekeres, Monika ; Oberhuber, Georg ; Krohn, Karsten ; Hengstschlaeger, Markus ; Krupitza, Georg ; Jayaram, Hiremagalur N. / Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells. In: Cell Death and Differentiation. 1999 ; Vol. 6, No. 8. pp. 736-744.
@article{75ee34cfd32c4f9e97d4cf6943ca345c,
title = "Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells",
abstract = "One of the mechanisms of action of a new oncolytic agent, benzamide riboside (BR) is by inhibiting inosine 5'-monophosphate dehydrogenase (IMPDH) which catalyzes the formation of xanthine 5'-monophosphate from inosine 5'-monophosphate and nicotinamide adenine dinucleotide, thereby restricting the biosynthesis of guanylates. In the present study BR (10-20 μM) induced apoptosis in a human ovarian carcinoma N.1 cell line (a monoclonal derivative of its heterogenous parent line HOC-7). This was ascertained by DNA fragmentation, TUNEL assay, [poly(ADP)ribose polymerase]-cleavage and alteration in cell morphology. Apoptosis was accompanied by sustained c-Myc expression, concurrent down-regulation of cdc25A mRNA and protein, and by inhibition of Cdk2 activity. Both Cdk2 and cdc25A are G1 phase specific genes and Cdk2 is the target of Cdc25A. These studies demonstrate that BR exhibits dual mechanisms of action, first by inhibiting IMPDH, and second by inducing apoptosis, which is associated with repression of components of the cell cycle that are downstream of constitutive c-Myc expression.",
keywords = "Apoptosis, Benzamide riboside, c-myc induction, Cdc25A repression, Cyclin D1/prad 1 expression, IMP dehydrogenase inhibitor",
author = "Michael Grusch and Georg Rosenberger and Gerhard Fuhrmann and Katja Braun and Birgit Titscher and Thomas Szekeres and Monika Fritzer-Skekeres and Georg Oberhuber and Karsten Krohn and Markus Hengstschlaeger and Georg Krupitza and Jayaram, {Hiremagalur N.}",
year = "1999",
month = "8",
language = "English",
volume = "6",
pages = "736--744",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells

AU - Grusch, Michael

AU - Rosenberger, Georg

AU - Fuhrmann, Gerhard

AU - Braun, Katja

AU - Titscher, Birgit

AU - Szekeres, Thomas

AU - Fritzer-Skekeres, Monika

AU - Oberhuber, Georg

AU - Krohn, Karsten

AU - Hengstschlaeger, Markus

AU - Krupitza, Georg

AU - Jayaram, Hiremagalur N.

PY - 1999/8

Y1 - 1999/8

N2 - One of the mechanisms of action of a new oncolytic agent, benzamide riboside (BR) is by inhibiting inosine 5'-monophosphate dehydrogenase (IMPDH) which catalyzes the formation of xanthine 5'-monophosphate from inosine 5'-monophosphate and nicotinamide adenine dinucleotide, thereby restricting the biosynthesis of guanylates. In the present study BR (10-20 μM) induced apoptosis in a human ovarian carcinoma N.1 cell line (a monoclonal derivative of its heterogenous parent line HOC-7). This was ascertained by DNA fragmentation, TUNEL assay, [poly(ADP)ribose polymerase]-cleavage and alteration in cell morphology. Apoptosis was accompanied by sustained c-Myc expression, concurrent down-regulation of cdc25A mRNA and protein, and by inhibition of Cdk2 activity. Both Cdk2 and cdc25A are G1 phase specific genes and Cdk2 is the target of Cdc25A. These studies demonstrate that BR exhibits dual mechanisms of action, first by inhibiting IMPDH, and second by inducing apoptosis, which is associated with repression of components of the cell cycle that are downstream of constitutive c-Myc expression.

AB - One of the mechanisms of action of a new oncolytic agent, benzamide riboside (BR) is by inhibiting inosine 5'-monophosphate dehydrogenase (IMPDH) which catalyzes the formation of xanthine 5'-monophosphate from inosine 5'-monophosphate and nicotinamide adenine dinucleotide, thereby restricting the biosynthesis of guanylates. In the present study BR (10-20 μM) induced apoptosis in a human ovarian carcinoma N.1 cell line (a monoclonal derivative of its heterogenous parent line HOC-7). This was ascertained by DNA fragmentation, TUNEL assay, [poly(ADP)ribose polymerase]-cleavage and alteration in cell morphology. Apoptosis was accompanied by sustained c-Myc expression, concurrent down-regulation of cdc25A mRNA and protein, and by inhibition of Cdk2 activity. Both Cdk2 and cdc25A are G1 phase specific genes and Cdk2 is the target of Cdc25A. These studies demonstrate that BR exhibits dual mechanisms of action, first by inhibiting IMPDH, and second by inducing apoptosis, which is associated with repression of components of the cell cycle that are downstream of constitutive c-Myc expression.

KW - Apoptosis

KW - Benzamide riboside

KW - c-myc induction

KW - Cdc25A repression

KW - Cyclin D1/prad 1 expression

KW - IMP dehydrogenase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0032836084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032836084&partnerID=8YFLogxK

M3 - Article

C2 - 10467347

AN - SCOPUS:0032836084

VL - 6

SP - 736

EP - 744

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 8

ER -